Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab

Shalini Yalamanchi, Harry W Flynn Jr.Department of Ophthalmology, Bascom Palmer Eye Institute, Miami Miller School of Medicine Miami, FL, USAAbstract: A 39-year-old male with decreased visual acuity and extensive macular hemorrhage and edema secondary to a hemiretinal vein occlusion was treated with...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yalamanchi S, Flynn HW Jr.
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/0e97657f6c7b46ce996231563dda28a2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0e97657f6c7b46ce996231563dda28a2
record_format	dspace
spelling	oai:doaj.org-article:0e97657f6c7b46ce996231563dda28a22021-12-02T02:29:31ZHemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab1177-54671177-5483https://doaj.org/article/0e97657f6c7b46ce996231563dda28a22011-10-01T00:00:00Zhttp://www.dovepress.com/hemiretinal-vein-occlusion-with-macular-hemorrhage-and-edema-treated-w-a8473https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Shalini Yalamanchi, Harry W Flynn Jr.Department of Ophthalmology, Bascom Palmer Eye Institute, Miami Miller School of Medicine Miami, FL, USAAbstract: A 39-year-old male with decreased visual acuity and extensive macular hemorrhage and edema secondary to a hemiretinal vein occlusion was treated with multiple intravitreal injections of bevacizumab 1.25 mg every four to six weeks for over one year. Treatment outcomes were assessed by visual acuity and Cirrus spectral domain optical coherence tomography. Treatment resulted in ongoing visual and anatomic improvement, with resolution at the last visit.Keywords: retinal vein occlusion, macular edema, bevacizumabYalamanchi SFlynn HW Jr.Dove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 1509-1513 (2011)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Yalamanchi S Flynn HW Jr. Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
description	Shalini Yalamanchi, Harry W Flynn Jr.Department of Ophthalmology, Bascom Palmer Eye Institute, Miami Miller School of Medicine Miami, FL, USAAbstract: A 39-year-old male with decreased visual acuity and extensive macular hemorrhage and edema secondary to a hemiretinal vein occlusion was treated with multiple intravitreal injections of bevacizumab 1.25 mg every four to six weeks for over one year. Treatment outcomes were assessed by visual acuity and Cirrus spectral domain optical coherence tomography. Treatment resulted in ongoing visual and anatomic improvement, with resolution at the last visit.Keywords: retinal vein occlusion, macular edema, bevacizumab
format	article
author	Yalamanchi S Flynn HW Jr.
author_facet	Yalamanchi S Flynn HW Jr.
author_sort	Yalamanchi S
title	Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
title_short	Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
title_full	Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
title_fullStr	Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
title_full_unstemmed	Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
title_sort	hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
publisher	Dove Medical Press
publishDate	2011
url	https://doaj.org/article/0e97657f6c7b46ce996231563dda28a2
work_keys_str_mv	AT yalamanchis hemiretinalveinocclusionwithmacularhemorrhageandedematreatedwithintravitrealbevacizumab AT flynnhwjr hemiretinalveinocclusionwithmacularhemorrhageandedematreatedwithintravitrealbevacizumab
_version_	1718402450326552576

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab

Ejemplares similares